Androgenetic Alopecia: Diagnosis Topical Map: SEO Clusters
Use this Androgenetic Alopecia: Diagnosis and Treatment Options topical map to cover what causes androgenetic alopecia with topic clusters, pillar pages, article ideas, content briefs, AI prompts, and publishing order.
Built for SEOs, agencies, bloggers, and content teams that need a practical content plan for Google rankings, AI Overview eligibility, and LLM citation.
1. Understanding Androgenetic Alopecia
Foundational coverage of what AGA is, who gets it, and how it develops — essential for credibility and for readers to grasp why specific treatments work. This group explains biology, genetics, patterns and the natural history of the condition.
Androgenetic Alopecia Explained: Causes, Pathophysiology, and Pattern Hair Loss
Comprehensive review of the biological mechanisms behind AGA, including the role of androgens (DHT), androgen receptors, hair cycle changes and follicular miniaturization; covers epidemiology, natural history and clinical patterning in men and women. Readers gain a deep understanding that informs treatment choices and expectation-setting.
Epidemiology and Risk Factors for Androgenetic Alopecia
Data-driven review of incidence and prevalence across age groups, sexes and populations, plus modifiable and non-modifiable risk factors (smoking, BMI, stress, medications).
Genetics of Androgenetic Alopecia: What Family History Predicts
Explains polygenic inheritance, key loci (AR gene, 20p11), predictive value of family history, and limitations of genetic testing for AGA.
How DHT Causes Hair Miniaturization: Mechanisms and Evidence
Mechanistic deep dive into androgen metabolism in the scalp, 5-alpha reductase isoenzymes, receptor signaling and histopathologic changes seen in AGA.
Staging Androgenetic Alopecia: Norwood, Ludwig and Other Classification Systems
Practical guide to staging AGA with photos, how to document progression, and clinical uses of each scale.
Common Myths and Misconceptions About Male and Female Pattern Hair Loss
Short myth-busting article addressing diet myths, shampoo myths, cutting hair myths, and non-evidence-based 'cures'.
2. Diagnosis and Clinical Evaluation
Practical diagnostic guidance for clinicians and informed patients — covers when and how to evaluate AGA, useful tests, imaging and how to rule out other causes of hair loss.
Diagnosing Androgenetic Alopecia: Clinical Assessment, Trichoscopy, and Laboratory Evaluation
Step-by-step clinical approach including history, scalp exam, trichoscopy features, recommended laboratory work-up in men and women, and when to biopsy. The pillar acts as a diagnostic algorithm clinicians can follow and patients can use to understand work-up rationale.
Clinical Examination and Pattern Recognition in AGA
Guided checklist for clinicians with photos: how to document hair density, miniaturization, and progression.
Trichoscopy (Dermoscopy) for Androgenetic Alopecia: A Practical Guide
Hands-on guide to trichoscopic signs of AGA (anisotrichosis, vellus hairs, yellow dots), device recommendations and photo examples.
When and Which Laboratory Tests to Order for Hair Loss (Men vs Women)
Evidence-based list of blood tests (androgen levels, TSH, ferritin, CBC) with interpretation, timing and tests to avoid.
Scalp Biopsy in Suspected Androgenetic Alopecia: Technique and Pathology Report
When to biopsy, punch technique (double biopsy approach), and how to read pathology results differentiating AGA from other conditions.
Differential Diagnosis: How to Distinguish AGA from Other Forms of Hair Loss
Comparative features (history, trichoscopy, labs) that distinguish telogen effluvium, alopecia areata, traction/scarring alopecia and diffuse causes.
3. Medical Treatments (Drug and Topical Therapy)
Complete, evidence-based guide to pharmacologic treatments — FDA-approved and off-label — including mechanisms, efficacy, safety, dosing and monitoring. This is core content for treatment-seeking users.
Medical Treatments for Androgenetic Alopecia: An Evidence-Based Guide to Topicals and Systemic Therapy
Authoritative review of all major medical options (topical minoxidil, oral 5-alpha reductase inhibitors, antiandrogens for women, topical formulations and nutraceuticals), including comparative efficacy, timelines, side-effect profiles and patient selection to guide clinical decisions.
Topical Minoxidil: Formulations, How to Use, Side Effects and Efficacy
Practical guide covering 2% vs 5% vs foam, application technique, expected timeline, management of shedding and contact dermatitis.
Oral Finasteride and Dutasteride: Mechanism, Dosing, Efficacy and Safety
Compares finasteride and dutasteride head-to-head, details sexual and systemic side effects, fertility considerations and monitoring recommendations.
Antiandrogen Options for Women: Spironolactone, Oral Contraceptives and Alternatives
Evidence and practical guidance for using spironolactone, combined oral contraceptives, cyproterone acetate (where available) and considerations for monitoring and pregnancy risk.
Topical Antiandrogens and Compounded Therapies: Evidence and Practical Use
Review of topical finasteride, clascoterone and compounded combination formulas — what data exist and when to consider them.
Supplements and Nutraceuticals for Hair Loss: What Works and What Doesn’t
Evaluates biotin, saw palmetto, iron, vitamin D and other common supplements with evidence grading and recommended testing before use.
4. Procedural and Device Therapies
In-depth coverage of procedural options that complement or replace medical therapy — critical for patients considering PRP, microneedling, LLLT or surgical hair restoration.
Procedural and Device Therapies for Androgenetic Alopecia: PRP, Microneedling, LLLT and Hair Transplantation
Detailed analysis of procedural interventions: indications, evidence base, protocols, expected outcomes, complications and how to combine procedures with medical therapy. Includes decision pathways for selecting hair transplantation vs nonsurgical approaches.
Hair Transplantation: FUE vs FUT, Planning, Candidacy and Outcomes
Comprehensive patient-facing guide to transplant techniques, donor assessment, graft survival, density planning, complications and long-term expectations.
Platelet-Rich Plasma (PRP) for Androgenetic Alopecia: Protocols and Evidence
Protocol variations, injection techniques, number/timing of sessions, and a meta-analysis summary of efficacy and limitations.
Microneedling for Hair Loss: Evidence, Protocols and Combination Therapies
Mechanisms of action, device settings, how microneedling augments topical and PRP therapy, and safety considerations.
Low-Level Laser Therapy (LLLT) Devices: How to Choose and What to Expect
Evaluation of helmet/comb devices, dosing schedules, clinical trial data and patient selection for LLLT.
Scalp Micropigmentation: Cosmetic Camouflage and Indications
What scalp micropigmentation can and cannot achieve, procedural steps, longevity and when to choose it vs transplantation.
5. Emerging and Experimental Treatments
Covers cutting-edge science and clinical trials — important for long-term authority and readers seeking future or investigational options.
Future Treatments for Androgenetic Alopecia: Stem Cells, Hair Cloning, Small Molecules and Ongoing Clinical Trials
Survey of the treatment pipeline including JAK inhibitors, Wnt pathway activators, hair cloning/multiplication technologies, and gene therapy approaches — explains current clinical evidence, timelines and safety considerations.
JAK Inhibitors and Immune-Targeted Therapies: Evidence for Hair Regrowth
Summarizes trials of JAK inhibitors in alopecia areata and emerging data relevant to AGA, safety profiles and off-label considerations.
Hair Cloning and Stem Cell Approaches: Progress, Challenges and Timelines
Explains hair follicle neogenesis strategies, major companies and labs, scientific hurdles and realistic timelines for clinical availability.
Small Molecules, Wnt Pathway and Growth-Factor Therapies in Development
Review of candidate drugs targeting growth pathways (Wnt, prostaglandin analogs) and what preclinical/clinical data show so far.
How to Interpret Clinical Trials and Enroll in Research for Hair Loss
Practical primer on trial phases, endpoints (hair count vs patient-reported outcomes), safety monitoring and how to find legitimate trials.
6. Management, Patient Journey and Quality of Life
Actionable resources for building long-term, patient-centered treatment plans, managing side effects, cosmetic alternatives and psychosocial support — necessary for patient retention and trust.
Managing Androgenetic Alopecia Long-Term: Treatment Plans, Monitoring, Costs and Psychological Support
Practical guide to creating individualized, evidence-based treatment plans; monitoring outcomes; handling adverse effects and costs; and addressing the psychological impact of hair loss for sustained adherence and improved quality of life.
Creating Individualized Treatment Plans for Androgenetic Alopecia
Step-by-step examples for different patient archetypes (young man early AGA, woman with diffuse thinning, transplant candidate) including sequencing and combination therapy.
Adherence, Side-Effect Management and Counseling to Improve Outcomes
Behavioral and clinical strategies to improve long-term adherence, how to counsel about sexual/dermatologic side effects, and when to switch therapy.
Costs, Insurance and Choosing a Clinic: Questions to Ask Before Treatment
Practical checklist for comparing clinics, understanding pricing (PRP, transplants, devices), and insurance/coverage realities.
Cosmetic Camouflage and Styling Tips for Thinning Hair
Actionable styling advice, product recommendations (fibers, sprays), and noninvasive cosmetic options to improve visible density.
Psychological Impact and Support Resources for People with Hair Loss
Discusses mental health burden, screening for depression/anxiety, peer support groups and resources for counseling.
Content strategy and topical authority plan for Androgenetic Alopecia: Diagnosis and Treatment Options
Building topical authority on AGA matters because search demand is large, sustained, and commercially valuable—patients search for diagnosis, treatment options, and clinics with high conversion intent. Ranking dominance requires owning the clinical-to-consumer journey (diagnosis, medical therapy, procedures, post-care) so sites capture both informational traffic and high-value leads for procedures and telemedicine.
The recommended SEO content strategy for Androgenetic Alopecia: Diagnosis and Treatment Options is the hub-and-spoke topical map model: one comprehensive pillar page on Androgenetic Alopecia: Diagnosis and Treatment Options, supported by 29 cluster articles each targeting a specific sub-topic. This gives Google the complete hub-and-spoke coverage it needs to rank your site as a topical authority on Androgenetic Alopecia: Diagnosis and Treatment Options.
Seasonal pattern: Year-round evergreen interest with modest search spikes in January (New Year/resolution checkups) and spring/summer months (April–June) when cosmetic concerns and event-driven consultations rise.
35
Articles in plan
6
Content groups
21
High-priority articles
~6 months
Est. time to authority
Search intent coverage across Androgenetic Alopecia: Diagnosis and Treatment Options
This topical map covers the full intent mix needed to build authority, not just one article type.
Content gaps most sites miss in Androgenetic Alopecia: Diagnosis and Treatment Options
These content gaps create differentiation and stronger topical depth.
- Patient-centered decision trees that map stage of AGA (Ludwig/ Norwood) to evidence-based first-line, second-line, and combination options with expected timelines and costs.
- Clear, clinic-validated protocols for PRP (preparation, dosing, frequency) and real-world success rates instead of vague marketing claims.
- Long-term adherence and discontinuation outcomes for medical therapies with pragmatic tips to manage side effects and minimize relapse.
- Transparent cost benchmarks and financing options for common pathways (medical management vs PRP vs transplant) by region/market.
- Female-specific guidance: hormone testing algorithms, anti-androgen therapy selection, pregnancy planning, and menopausal considerations.
- Comparative analysis of topical vs oral DHT inhibitors (finasteride vs dutasteride vs topical formulations) with safety profiles and off-label considerations.
- Implementation guides for integrating teledermatology and trichoscopy into remote diagnosis workflows including image protocols and red flags for in-person referral.
- Post-transplant long-term management: staged planning, adjuvant medical therapy, and monitoring to prevent donor area depletion and manage progression.
Entities and concepts to cover in Androgenetic Alopecia: Diagnosis and Treatment Options
Common questions about Androgenetic Alopecia: Diagnosis and Treatment Options
How is androgenetic alopecia (AGA) diagnosed clinically?
Diagnosis is primarily clinical based on progressive patterned hair thinning (male- or female-pattern) and scalp examination including hair pull and trichoscopy. Blood tests or scalp biopsy are reserved for atypical presentations, rapid loss, or when another diagnosis (alopecia areata, telogen effluvium) is suspected.
What tests should I get to evaluate hair loss from suspected AGA?
For typical AGA no routine labs are required, but clinicians often check thyroid function, ferritin, and in women serum androgens (total testosterone, DHEA-S, SHBG) if signs of hyperandrogenism appear. A scalp biopsy or trichoscopy can confirm miniaturization when diagnosis is uncertain.
How effective is topical minoxidil and how long until results?
Topical minoxidil produces visible regrowth or stabilization in roughly 30–60% of patients, with initial shedding sometimes seen; meaningful results typically appear between 3–6 months and peak at about 12 months. Continued use is required to maintain gains; stopping leads to return to baseline within months.
Does oral finasteride stop hair loss and what are the risks?
Oral finasteride 1 mg reduces hair loss progression in most men and increases hair counts in many, with clinical trials showing preservation or improvement in the majority over 12 months. Risks include sexual side effects in a small percentage, and it is contraindicated in women of childbearing potential due to teratogenicity.
What are the evidence and expected outcomes for hair transplant surgery in AGA?
Follicular unit transplantation (FUT) and follicular unit extraction (FUE) can produce permanent density improvements using donor hair, with realistic patient expectations tied to donor supply and disease progression. Transplants do not stop native hair loss, so combining medical therapy (minoxidil/finasteride) and staged planning is essential for long-term results.
Is platelet-rich plasma (PRP) effective for AGA?
PRP has moderate-quality evidence showing improvement in hair density and thickness for some patients when delivered in multiple sessions, but protocols and results vary widely between clinics. PRP is best considered an adjunctive therapy rather than a standalone definitive treatment.
What are the best treatment options for women with androgenetic alopecia?
Topical minoxidil 2%–5% is first-line for most women; oral anti-androgens (spironolactone, cyproterone acetate where available) or low-dose finasteride can be considered in selected patients after endocrine evaluation. Management must account for pregnancy potential, menopausal status, and cosmetic goals.
Can genetic testing predict my risk of AGA or response to treatments?
Genetic tests can indicate predisposition by identifying risk loci but currently have limited clinical utility for predicting individual progression or treatment response. Clinical phenotype, family history, and response to therapy remain more actionable for treatment planning.
How long should I try a treatment before deciding it isn't working?
Allow at least 6–12 months for medical therapies like minoxidil or finasteride to show meaningful benefit; procedural outcomes (PRP, transplants) often require multi-session or staged assessment over 9–12 months. Assessments should combine standardized photos, patient-reported outcomes, and trichoscopic measurements.
Will insurance cover AGA treatments such as hair transplants or medications?
Most insurers consider AGA cosmetic, so hair transplants and topical/oral treatments are usually out-of-pocket; exceptions exist for reconstructive cases or where a medical diagnosis is linked to other covered conditions. Clear cost estimates and financing options are important content for patient-facing sites.
Publishing order
Start with the pillar page, then publish the 21 high-priority articles first to establish coverage around what causes androgenetic alopecia faster.
Estimated time to authority: ~6 months
Who this topical map is for
Clinic owners, dermatologists, hair transplant surgeons, and health publishers aiming to create an authoritative patient + clinician resource on AGA diagnosis and treatment.
Goal: Establish a single comprehensive pillar that converts readers to clinic consultations, telemedicine visits, and premium guides while ranking for both informational and commercial AGA queries.